Jayaraman Seetharaman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jayaraman Seetharaman has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Karlo Lopez
School of Natural Sciences Mathematics and Engineering California State University Bakersfield CA 93311 USA
4 shared publications - Marcus Fischer
Department of Chemical Biology & Therapeutics MS 1000 St. Jude Children's Research Hospital Memphis TN USA
4 shared publications - Murugendra Vanarotti
Department of Chemical Biology & Therapeutics St. Jude Children's Research Hospital Memphis TN 38105 USA
4 shared publications - Timothy R. Stachowski
Department of Chemical Biology & Therapeutics MS 1000 St. Jude Children's Research Hospital Memphis TN USA
4 shared publications - Andrew D. Huber
St. Jude Children’s Research Hospital
1 shared publication - Chacko Jobichen
Centre for Advanced Microscopy Australian National University Canberra Australian Capital Territory Australia
1 shared publication
Latest Publications
- Open Access
- 18 May 2023
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 385 (S3) , 123
Structure-guided approach to modulate small molecule binding to the promiscuous pregnane X receptor
ID 52403 Poster Board 123 Ligand-binding promiscuity in detoxification systems protects the body from toxicological harm but is a roadblock to drug development due to the difficulty in optimizing small molecules to both retain target potency and avoid metabolic events. Immense effort is invested in evaluating metabolism of molecules to develop safer, more effective treatments, but engineering specificity into or out of promiscuous proteins and their ligands is a challenging task. To better understand the promiscuous nature of detoxification networks, we have used X-ray crystallography to characterize a structural feature of pregnane X receptor (PXR), a nuclear receptor that is activated by diverse molecules (with different structures and sizes) to upregulate transcription of drug metabolism genes. We found that large ligands expand PXR’s ligand binding pocket, and the ligand-induced expansion occurs through a specific unfavorable compound-protein clash that likely contributes to reduced binding affinity. Removing the clash by compound modification resulted in more favorable binding modes with significantly enhanced binding affinity. We then engineered the unfavorable ligand-protein clash into a potent, small PXR ligand, resulting in marked reduction of PXR binding and activation. Structural analysis showed that PXR is remodeled and that the modified ligands reposition in the binding pocket to avoid clashes, but the combined protein/ligand conformational changes result in less favorable binding modes. Thus, ligand-induced binding pocket expansion increases ligand-binding potential of PXR but is an unfavorable event; therefore, drug candidates can be engineered to expand PXR9s ligand binding pocket and reduce their safety liability due to PXR binding. Research reported in this publication was supported by ALSAC and National Institutes of Health National Institute of General Medical Sciences [Grant R35GM118041]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work utilized the FMX and AMX beamlines, which are primarily supported by the National Institutes of Health National Institute of General Medical Sciences through a Center Core P30 Grant (P30GM133893), and by the U.S. Department of Energy Office of Biological and Environmental Research (KP1607011). As part of the National Synchrotron Light Source II, a national user facility at Brookhaven National Laboratory, work performed at the Center for BioMolecular Structures is supported in part by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences Program under contract number DE-SC0012704.
- 18 May 2023
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 385 (S3) , 123
Open AccessStructure-guided approach to modulate small molecule binding to the promiscuous pregnane X receptor
ID 52403 Poster Board 123 Ligand-binding promiscuity in detoxification systems protects the body from toxicological harm but is a roadblock to drug development due to the difficulty in optimizing small molecules to both retain target potency and avoid metabolic events. Immense effort is invested in evaluating metabolism of molecules to develop safer, more effective treatments, but engineering specificity into or out of promiscuous proteins and their ligands is a challenging task. To better understand the promiscuous nature of detoxification networks, we have used X-ray crystallography to characterize a structural feature of pregnane X receptor (PXR), a nuclear receptor that is activated by diverse molecules (with different structures and sizes) to upregulate transcription of drug metabolism genes. We found that large ligands expand PXR’s ligand binding pocket, and the ligand-induced expansion occurs through a specific unfavorable compound-protein clash that likely contributes to reduced binding affinity. Removing the clash by compound modification resulted in more favorable binding modes with significantly enhanced binding affinity. We then engineered the unfavorable ligand-protein clash into a potent, small PXR ligand, resulting in marked reduction of PXR binding and activation. Structural analysis showed that PXR is remodeled and that the modified ligands reposition in the binding pocket to avoid clashes, but the combined protein/ligand conformational changes result in less favorable binding modes. Thus, ligand-induced binding pocket expansion increases ligand-binding potential of PXR but is an unfavorable event; therefore, drug candidates can be engineered to expand PXR9s ligand binding pocket and reduce their safety liability due to PXR binding. Research reported in this publication was supported by ALSAC and National Institutes of Health National Institute of General Medical Sciences [Grant R35GM118041]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work utilized the FMX and AMX beamlines, which are primarily supported by the National Institutes of Health National Institute of General Medical Sciences through a Center Core P30 Grant (P30GM133893), and by the U.S. Department of Energy Office of Biological and Environmental Research (KP1607011). As part of the National Synchrotron Light Source II, a national user facility at Brookhaven National Laboratory, work performed at the Center for BioMolecular Structures is supported in part by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences Program under contract number DE-SC0012704.
- 25 July 2022
- Published by Wiley in Angewandte Chemie
- Vol. 134 (31)
Frontispiz: Water Networks Repopulate Protein–Ligand Interfaces with Temperature
- 25 July 2022
- Published by Wiley in Angewandte Chemie
- Vol. 134 (31)
Frontispiz: Water Networks Repopulate Protein–Ligand Interfaces with Temperature
- 25 July 2022
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 61 (31)
Frontispiece: Water Networks Repopulate Protein–Ligand Interfaces with Temperature
- 25 July 2022
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 61 (31)
Frontispiece: Water Networks Repopulate Protein–Ligand Interfaces with Temperature
- Open Access
- 21 June 2022
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 61 (31) , e202112919
Water Networks Repopulate Protein–Ligand Interfaces with Temperature
High‐resolution crystal structures highlight the importance of water networks in protein–ligand interactions. However, as these are typically determined at cryogenic temperature, resulting insights may be structurally precise but not biologically accurate. By collecting 10 matched room‐temperature and cryogenic datasets of the biomedical target Hsp90α, we identified changes in water networks that impact protein conformations at the ligand binding interface. Water repositioning with temperature repopulates protein ensembles and ligand interactions. We introduce Flipper conformational barcodes to identify temperature‐sensitive regions in electron density maps. This revealed that temperature‐responsive states coincide with ligand‐responsive regions and capture unique binding signatures that disappear upon cryo‐cooling. Our results have implications for discovering Hsp90 selective ligands, and, more generally, for the utility of hidden protein and water conformations in drug discovery.
- 21 June 2022
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 61 (31) , e202112919
Open AccessWater Networks Repopulate Protein–Ligand Interfaces with Temperature
High‐resolution crystal structures highlight the importance of water networks in protein–ligand interactions. However, as these are typically determined at cryogenic temperature, resulting insights may be structurally precise but not biologically accurate. By collecting 10 matched room‐temperature and cryogenic datasets of the biomedical target Hsp90α, we identified changes in water networks that impact protein conformations at the ligand binding interface. Water repositioning with temperature repopulates protein ensembles and ligand interactions. We introduce Flipper conformational barcodes to identify temperature‐sensitive regions in electron density maps. This revealed that temperature‐responsive states coincide with ligand‐responsive regions and capture unique binding signatures that disappear upon cryo‐cooling. Our results have implications for discovering Hsp90 selective ligands, and, more generally, for the utility of hidden protein and water conformations in drug discovery.
- Open Access
- 20 June 2022
- Published by Wiley in Angewandte Chemie
- Vol. 134 (31)
Water Networks Repopulate Protein–Ligand Interfaces with Temperature
High‐resolution crystal structures highlight the importance of water networks in protein–ligand interactions. However, as these are typically determined at cryogenic temperature, resulting insights may be structurally precise but not biologically accurate. By collecting 10 matched room‐temperature and cryogenic datasets of the biomedical target Hsp90α, we identified changes in water networks that impact protein conformations at the ligand binding interface. Water repositioning with temperature repopulates protein ensembles and ligand interactions. We introduce Flipper conformational barcodes to identify temperature‐sensitive regions in electron density maps. This revealed that temperature‐responsive states coincide with ligand‐responsive regions and capture unique binding signatures that disappear upon cryo‐cooling. Our results have implications for discovering Hsp90 selective ligands, and, more generally, for the utility of hidden protein and water conformations in drug discovery.
- 20 June 2022
- Published by Wiley in Angewandte Chemie
- Vol. 134 (31)
Open AccessWater Networks Repopulate Protein–Ligand Interfaces with Temperature
High‐resolution crystal structures highlight the importance of water networks in protein–ligand interactions. However, as these are typically determined at cryogenic temperature, resulting insights may be structurally precise but not biologically accurate. By collecting 10 matched room‐temperature and cryogenic datasets of the biomedical target Hsp90α, we identified changes in water networks that impact protein conformations at the ligand binding interface. Water repositioning with temperature repopulates protein ensembles and ligand interactions. We introduce Flipper conformational barcodes to identify temperature‐sensitive regions in electron density maps. This revealed that temperature‐responsive states coincide with ligand‐responsive regions and capture unique binding signatures that disappear upon cryo‐cooling. Our results have implications for discovering Hsp90 selective ligands, and, more generally, for the utility of hidden protein and water conformations in drug discovery.
- Open Access
- 1 May 2020
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 295 (22) , 7635-7652
The genome of a Bacteroidetes inhabitant of the human gut encodes a structurally distinct enoyl-acyl carrier protein reductase (FabI)
- 1 May 2020
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 295 (22) , 7635-7652
Open AccessThe genome of a Bacteroidetes inhabitant of the human gut encodes a structurally distinct enoyl-acyl carrier protein reductase (FabI)
- Open Access
- 7 September 2018
- Published by Wiley in The FEBS Journal
- Vol. 285 (21) , 4060-4070
Structural basis for the pathogenesis of Campylobacter jejuni Hcp1, a structural and effector protein of the Type VI Secretion System
The Type VI Secretion System (T6SS) provides enhanced virulence to Campylobacter jejuni and has been associated with a high incidence of bloody diarrhea. The hemolysin‐coregulated protein (Hcp)—the hallmark of the T6SS—can act as a structural and effector protein. Unlike other T6SS‐harboring bacteria, which possess multiple Hcp proteins each performing different functions, C. jejuni possesses only one Hcp protein, and its structural and functional role has not been elucidated previously. Here, we report the structure and functional studies of Hcp from C. jejuni. We found similarities between the hexameric ring structure of Hcp‐Cj and that of Hcp3 from Pseudomonas aeruginosa. Through functional studies, we showed two roles for Hcp‐Cj that is, in cytotoxicity toward HepG2 cells and in biofilm formation in C. jejuni. In structure‐based mutational analyses, we showed that an Arg‐to‐Ala mutation at position 30 within the extended loop results in a significant decrease in cytotoxicity, suggesting a role for this loop in binding to the host cell. However, this mutation does not affect its biofilm formation function. Collectively, this study supports the dual role of Hcp‐Cj as a structural and effector protein in C. jejuni.
- 7 September 2018
- Published by Wiley in The FEBS Journal
- Vol. 285 (21) , 4060-4070
Open AccessStructural basis for the pathogenesis of Campylobacter jejuni Hcp1, a structural and effector protein of the Type VI Secretion System
The Type VI Secretion System (T6SS) provides enhanced virulence to Campylobacter jejuni and has been associated with a high incidence of bloody diarrhea. The hemolysin‐coregulated protein (Hcp)—the hallmark of the T6SS—can act as a structural and effector protein. Unlike other T6SS‐harboring bacteria, which possess multiple Hcp proteins each performing different functions, C. jejuni possesses only one Hcp protein, and its structural and functional role has not been elucidated previously. Here, we report the structure and functional studies of Hcp from C. jejuni. We found similarities between the hexameric ring structure of Hcp‐Cj and that of Hcp3 from Pseudomonas aeruginosa. Through functional studies, we showed two roles for Hcp‐Cj that is, in cytotoxicity toward HepG2 cells and in biofilm formation in C. jejuni. In structure‐based mutational analyses, we showed that an Arg‐to‐Ala mutation at position 30 within the extended loop results in a significant decrease in cytotoxicity, suggesting a role for this loop in binding to the host cell. However, this mutation does not affect its biofilm formation function. Collectively, this study supports the dual role of Hcp‐Cj as a structural and effector protein in C. jejuni.